Trio Medicines competitive analysis

Loading summary...

Explore patent oppositions filed by Trio Medicines against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 23, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Gastrin Antagonists (Eg Yf476, Netazepide) For Treatment And Prevention Of OsteoporosisCL BIOSCIENCESNov 17, 2021

Latest publications and patents of Trio Medicines New

Explore the latest publications and patents granted to Trio Medicines, showcasing their recent innovations and technological advancements.

Latest PTAB cases involving Trio Medicines

Discover the latest PTAB cases involving Trio Medicines, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Trio Medicines with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
TRIO MEDICINES1 - - -
CL BIOSCIENCES - 1 - -